+Follow
K75
No personal profile
2
Follow
2
Followers
0
Topic
0
Badge
Posts
Hot
K75
08-14
Great article, would you like to share it?
Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3577767277931441","uuid":"3577767277931441","gmtCreate":1614674488120,"gmtModify":1764379339250,"name":"K75","pinyin":"k75","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/7bc847990154ccadc5726d7d9e068039","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":2,"tweetSize":1,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.04.11","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"4e86300037264823b9bb00ff44fc0f19-6","templateUuid":"4e86300037264823b9bb00ff44fc0f19","name":"Live trading challenger","description":"for 12 months","bigImgUrl":"https://community-static.tradeup.com/news/b76669c276447115bf9cde881b0cba68","smallImgUrl":"https://community-static.tradeup.com/news/6d5ffd25685d045ade4bb948ef8fd5c3","grayImgUrl":"https://community-static.tradeup.com/news/076cd4597f6ea22aabdd4f6a12b2c293","redirectLinkEnabled":0,"redirectLink":"https://www.tigerbrokers.com.sg/activity/market/2023/stock-contest?adcode=StockContest2023","hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.03","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":5600},{"badgeId":"3e5a625780d3411098f7e72115f69f0a-2","templateUuid":"3e5a625780d3411098f7e72115f69f0a","name":"Total trades","description":"Cumulative for 500 trades","bigImgUrl":"https://community-static.tradeup.com/news/2a7aad6bbb003528533cf7367bf71a7d","smallImgUrl":"https://community-static.tradeup.com/news/545c65027673fd17e3ac5c2df0917fc4","grayImgUrl":"https://community-static.tradeup.com/news/4875da396980e5cdbae95a7cbf265454","redirectLinkEnabled":0,"redirectLink":"https://www.tigerbrokers.com.sg/activity/market/2023/stock-contest?adcode=StockContest2023","hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":5100},{"badgeId":"e93d6aec3f8541a685bf0bdf8480c06e-5","templateUuid":"e93d6aec3f8541a685bf0bdf8480c06e","name":"Ace trader","description":"Top 10","bigImgUrl":"https://community-static.tradeup.com/news/71a2286cf1c2ed4ac872db75d2914b4d","smallImgUrl":"https://community-static.tradeup.com/news/95cd664634e0cafd4dd538f723a13053","grayImgUrl":"https://community-static.tradeup.com/news/f027bafd492bdca554224ca0bfb51d8f","redirectLinkEnabled":0,"redirectLink":"https://www.tigerbrokers.com.sg/activity/market/2023/stock-contest?adcode=StockContest2023","hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.03","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":5500},{"badgeId":"23f878ed27704312ae41c7f17e73b319-4","templateUuid":"23f878ed27704312ae41c7f17e73b319","name":"Annualised return","description":"Top 10%","bigImgUrl":"https://community-static.tradeup.com/news/15d4b5a89fa218ed3a35da1a05874cf6","smallImgUrl":"https://community-static.tradeup.com/news/16e2b28d75d7746886400fad4f4ec3e3","grayImgUrl":"https://community-static.tradeup.com/news/6f578d36f80e1a3d9c705f395e522048","redirectLinkEnabled":0,"redirectLink":"https://www.tigerbrokers.com.sg/activity/market/2023/stock-contest?adcode=StockContest2023","hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.13","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":5300},{"badgeId":"f8545949683242faa8dd0b48c38980be-5","templateUuid":"f8545949683242faa8dd0b48c38980be","name":"Monthly top 10 team’s member","description":"Top 10","bigImgUrl":"https://community-static.tradeup.com/news/dcb8ba4e1efd99be2b948dc3b81abfa8","smallImgUrl":"https://community-static.tradeup.com/news/a4aa0d1bc9d709e9af2662788ca5d144","grayImgUrl":"https://community-static.tradeup.com/news/5704f3dcb758b5392763b7709ebf548a","redirectLinkEnabled":0,"redirectLink":"https://www.tigerbrokers.com.sg/activity/market/2023/stock-contest?adcode=StockContest2023","hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.03","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":5400},{"badgeId":"f00de38e20574ad1abf55a15966547c8-6","templateUuid":"f00de38e20574ad1abf55a15966547c8","name":"Average winning trade","description":"Top 3%","bigImgUrl":"https://community-static.tradeup.com/news/a598d1c237f4abca28b7dec180a69b90","smallImgUrl":"https://community-static.tradeup.com/news/6b82de83729a6fa0c5bd4e93dcee29be","grayImgUrl":"https://community-static.tradeup.com/news/b7430ddcdaa39bc9a65efade13881001","redirectLinkEnabled":0,"redirectLink":"https://www.tigerbrokers.com.sg/activity/market/2023/stock-contest?adcode=StockContest2023","hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":5200},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.07","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.16%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.25%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":11,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":13,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":1,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":467371395985744,"gmtCreate":1755103749056,"gmtModify":1755104313890,"author":{"id":"3577767277931441","authorId":"3577767277931441","name":"K75","avatar":"https://community-static.tradeup.com/news/7bc847990154ccadc5726d7d9e068039","crmLevel":13,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577767277931441","idStr":"3577767277931441"},"themes":[],"htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/467371395985744","repostId":"2559609994","repostType":2,"repost":{"id":"2559609994","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"pubTimestamp":1755082841,"share":"https://ttm.financial/m/news/2559609994?lang=&edition=fundamental","pubTime":"2025-08-13 19:00","market":"nz","language":"en","title":"Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy","url":"https://stock-news.laohu8.com/highlight/detail?id=2559609994","media":"Reuters","summary":"Tilray Medical, a division of Tilray Brands, Inc., has announced a strategic partnership through its wholly-owned subsidiary, FL Group S.R.L., with L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A., an Italian pharmaceutical company. This collaboration aims to expand access to medical cannabis extracts across Italy. By combining FL Group's regulatory and distribution capabilities with Molteni's scientific expertise, the partnership seeks to enhance the availability of EU-GMP certified cannabis therapies. Additionally, Molteni will leverage its extensive network of healthcare professionals to provide targeted education on medical cannabis therapies, emphasizing pain management solutions. Tilray Medical continues to be a leader in the European medical cannabis market, with operations in Germany, Italy, Portugal, Poland, and the United Kingdom.Disclaimer: This news brief was created by Public Technologies using generative artificial intelligence. While PUBT strives to provide ","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy\n </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n Tilray Medical, a division of Tilray Brands, Inc., has announced a strategic partnership through its wholly-owned subsidiary, FL Group S.R.L., with L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A., an Italian pharmaceutical company. This collaboration aims to expand access to medical cannabis extracts across Italy. By combining FL Group's regulatory and distribution capabilities with Molteni's scientific expertise, the partnership seeks to enhance the availability of EU-GMP certified cannabis therapies. Additionally, Molteni will leverage its extensive network of healthcare professionals to provide targeted education on medical cannabis therapies, emphasizing pain management solutions. Tilray Medical continues to be a leader in the European medical cannabis market, with operations in Germany, Italy, Portugal, Poland, and the United Kingdom.\n </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9510473-en) on August 13, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-13 19:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy\n </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n Tilray Medical, a division of Tilray Brands, Inc., has announced a strategic partnership through its wholly-owned subsidiary, FL Group S.R.L., with L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A., an Italian pharmaceutical company. This collaboration aims to expand access to medical cannabis extracts across Italy. By combining FL Group's regulatory and distribution capabilities with Molteni's scientific expertise, the partnership seeks to enhance the availability of EU-GMP certified cannabis therapies. Additionally, Molteni will leverage its extensive network of healthcare professionals to provide targeted education on medical cannabis therapies, emphasizing pain management solutions. Tilray Medical continues to be a leader in the European medical cannabis market, with operations in Germany, Italy, Portugal, Poland, and the United Kingdom.\n </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9510473-en) on August 13, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4585":"ETF&股票定投概念","BK4588":"碎股","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","BK4112":"金融交易所和数据","BK4557":"大麻股","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","BK4547":"WSB热门概念","NDAQ":"纳斯达克OMX交易所","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","BK4596":"哈里斯概念","BK4007":"制药","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","TLRY":"Tilray Inc."},"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL9PqKr:1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2559609994","content_text":"Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy\n \n\n Tilray Medical, a division of Tilray Brands, Inc., has announced a strategic partnership through its wholly-owned subsidiary, FL Group S.R.L., with L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A., an Italian pharmaceutical company. This collaboration aims to expand access to medical cannabis extracts across Italy. By combining FL Group's regulatory and distribution capabilities with Molteni's scientific expertise, the partnership seeks to enhance the availability of EU-GMP certified cannabis therapies. Additionally, Molteni will leverage its extensive network of healthcare professionals to provide targeted education on medical cannabis therapies, emphasizing pain management solutions. Tilray Medical continues to be a leader in the European medical cannabis market, with operations in Germany, Italy, Portugal, Poland, and the United Kingdom.\n \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9510473-en) on August 13, 2025, and is solely responsible for the information contained therein.","news_type":1,"symbols_score_info":{"TLRY":0.9,"NDAQ":0.9}},"isVote":1,"tweetType":1,"viewCount":206,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":467371395985744,"gmtCreate":1755103749056,"gmtModify":1755104313890,"author":{"id":"3577767277931441","authorId":"3577767277931441","name":"K75","avatar":"https://community-static.tradeup.com/news/7bc847990154ccadc5726d7d9e068039","crmLevel":13,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577767277931441","idStr":"3577767277931441"},"themes":[],"htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/467371395985744","repostId":"2559609994","repostType":2,"repost":{"id":"2559609994","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"pubTimestamp":1755082841,"share":"https://ttm.financial/m/news/2559609994?lang=&edition=fundamental","pubTime":"2025-08-13 19:00","market":"nz","language":"en","title":"Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy","url":"https://stock-news.laohu8.com/highlight/detail?id=2559609994","media":"Reuters","summary":"Tilray Medical, a division of Tilray Brands, Inc., has announced a strategic partnership through its wholly-owned subsidiary, FL Group S.R.L., with L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A., an Italian pharmaceutical company. This collaboration aims to expand access to medical cannabis extracts across Italy. By combining FL Group's regulatory and distribution capabilities with Molteni's scientific expertise, the partnership seeks to enhance the availability of EU-GMP certified cannabis therapies. Additionally, Molteni will leverage its extensive network of healthcare professionals to provide targeted education on medical cannabis therapies, emphasizing pain management solutions. Tilray Medical continues to be a leader in the European medical cannabis market, with operations in Germany, Italy, Portugal, Poland, and the United Kingdom.Disclaimer: This news brief was created by Public Technologies using generative artificial intelligence. While PUBT strives to provide ","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy\n </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n Tilray Medical, a division of Tilray Brands, Inc., has announced a strategic partnership through its wholly-owned subsidiary, FL Group S.R.L., with L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A., an Italian pharmaceutical company. This collaboration aims to expand access to medical cannabis extracts across Italy. By combining FL Group's regulatory and distribution capabilities with Molteni's scientific expertise, the partnership seeks to enhance the availability of EU-GMP certified cannabis therapies. Additionally, Molteni will leverage its extensive network of healthcare professionals to provide targeted education on medical cannabis therapies, emphasizing pain management solutions. Tilray Medical continues to be a leader in the European medical cannabis market, with operations in Germany, Italy, Portugal, Poland, and the United Kingdom.\n </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9510473-en) on August 13, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-13 19:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy\n </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n Tilray Medical, a division of Tilray Brands, Inc., has announced a strategic partnership through its wholly-owned subsidiary, FL Group S.R.L., with L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A., an Italian pharmaceutical company. This collaboration aims to expand access to medical cannabis extracts across Italy. By combining FL Group's regulatory and distribution capabilities with Molteni's scientific expertise, the partnership seeks to enhance the availability of EU-GMP certified cannabis therapies. Additionally, Molteni will leverage its extensive network of healthcare professionals to provide targeted education on medical cannabis therapies, emphasizing pain management solutions. Tilray Medical continues to be a leader in the European medical cannabis market, with operations in Germany, Italy, Portugal, Poland, and the United Kingdom.\n </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9510473-en) on August 13, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4585":"ETF&股票定投概念","BK4588":"碎股","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","BK4112":"金融交易所和数据","BK4557":"大麻股","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","BK4547":"WSB热门概念","NDAQ":"纳斯达克OMX交易所","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","BK4596":"哈里斯概念","BK4007":"制药","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","TLRY":"Tilray Inc."},"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL9PqKr:1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2559609994","content_text":"Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy\n \n\n Tilray Medical, a division of Tilray Brands, Inc., has announced a strategic partnership through its wholly-owned subsidiary, FL Group S.R.L., with L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A., an Italian pharmaceutical company. This collaboration aims to expand access to medical cannabis extracts across Italy. By combining FL Group's regulatory and distribution capabilities with Molteni's scientific expertise, the partnership seeks to enhance the availability of EU-GMP certified cannabis therapies. Additionally, Molteni will leverage its extensive network of healthcare professionals to provide targeted education on medical cannabis therapies, emphasizing pain management solutions. Tilray Medical continues to be a leader in the European medical cannabis market, with operations in Germany, Italy, Portugal, Poland, and the United Kingdom.\n \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9510473-en) on August 13, 2025, and is solely responsible for the information contained therein.","news_type":1,"symbols_score_info":{"TLRY":0.9,"NDAQ":0.9}},"isVote":1,"tweetType":1,"viewCount":206,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}